Acute Stroke: A New Target for Endovascular Therapy
Diabetes, poor glycemic control linked to death, CV events after CABG
Lipid Forum II Highlights
Highlights from Lipid Forum 2015®: Focus on Hypertriglyceridemia
Lesion length of at least 16 cm, distal external elastic membrane area of 27 mm2 or less and minimum stent area of 12 mm2 or less were independent predictors of restenosis at 1 year among patients with peripheral artery disease who received a paclitaxel-eluting stent for femoropopliteal lesions, according to new data from the ZEPHYR registry.
Researchers performed a prospective, multicenter study to investigate the rate and predictive risk factors of 1-year restenosis in 690 patients in the ZEPHYR registry who were implanted with the Zilver PTX (Cook Medical) paclitaxel-eluting stent (PES). The study included 831 femoropopliteal lesions in 797 limbs. The mean lesion length was 17 ± 10 cm.
No commercial support for this activity.
Impact of sustained weight loss on AF draws more attention to benefits of lifestyle change
Novel mechanism, potential treatment strategies for CVD in patients with HIV
FDA advisory panel backs approval of PCSK9 inhibitors
This feature offers timely executive summaries of the most relevant journals in cardiology.
Snapshot summaries of recent study results in cardiology.
Your central portal for information presented at ACC 2015.
Your resource for news and videos from SCAI 2014.
This exclusive Healio resource provides you a comprehensive window into what your colleagues and key opinion leaders are saying about current and future drugs and devices and their impact on patient outcomes.
Related story »
View past polls »
Search Healio's robust listing of national and international medical meetings.
©2015 All Rights Reserved.